Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury
about
Targeting interleukin-1 in heart diseaseBiochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms.Cross-sex hormonal replacement: is this really effective? an experimental clue.Effect of Kineret® on ovarian ischemia reperfusion injury in a rat model.Analyses of changes in myocardial long non-coding RNA and mRNA profiles after severe hemorrhagic shock and resuscitation via RNA sequencing in a rat model
P2860
Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury
description
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2012
@uk
name
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@en
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@nl
type
label
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@en
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@nl
prefLabel
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@en
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@nl
P2093
P2860
P921
P356
P1476
Impact of an interleukin-1 rec ...... al ischemia/reperfusion injury
@en
P2093
Angelika Hagemann
Christina Grothusen
Jan Braesen
Jan Schoettler
Jochen Cremer
Tim Attmann
P2860
P304
P356
10.1100/2012/737585
P407
P577
2012-01-01T00:00:00Z